Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 08 Sep 2023

Expression of the ether-a-gò-gò-related gene 1 channel during B and T lymphocyte development: role in BCR and TCR signaling

in Cancer Immunity and Immunotherapy

Cesare Sala
Martina Staderini
Tiziano Lottini
Claudia Duranti
Gabriele Angelini
Gabriela Constantin
Annarosa Arcangeli

Frontiers in Immunology

doi 10.3389/fimmu.2023.1111471

2,021 views
3 citations

Clinical Trial

Published on 07 Sep 2023

Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy

in Cancer Immunity and Immunotherapy

Astrid Z. Johansen
Sif I. Novitski
Jessica X. Hjaltelin
Susann Theile
Mogens K. Boisen
Søren Brunak
Daniel H. Madsen
Dorte L. Nielsen
Inna M. Chen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1228907

2,625 views
3 citations

Review

Published on 07 Sep 2023

Immunomodulatory properties of the lymphatic endothelium in the tumor microenvironment

in Cancer Immunity and Immunotherapy

Cristina Viúdez-Pareja
Ewa Kreft
Melissa García-Caballero

Frontiers in Immunology

doi 10.3389/fimmu.2023.1235812

5,036 views
10 citations

Review

Published on 07 Sep 2023

Immunotherapy: a promising approach for glioma treatment

in Cancer Immunity and Immunotherapy

Feroza Yasinjan
Yang Xing
Huayue Geng
Rui Guo
Lei Yang
Ziling Liu
Hong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1255611

31,086 views
92 citations

Review

Published on 07 Sep 2023

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy

in Cancer Immunity and Immunotherapy

Yani Berckmans
Jolien Ceusters
Ann Vankerckhoven
Roxanne Wouters
Matteo Riva
An Coosemans

Frontiers in Immunology

doi 10.3389/fimmu.2023.1236965

3,407 views
4 citations

Editorial

Published on 07 Sep 2023

Editorial: The role of maintenance therapy (immunotherapy, targeted therapy, etc) in cancer control and biologic behavior of recurrent/metastatic cervical cancer

in Cancer Immunity and Immunotherapy

Xiaolin Li
Xianzheng Zhang
Aihua Li
Peng Xie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1281775

1,393 views

Editorial

Published on 07 Sep 2023

Editorial: Translation of genetically engineered T cells in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Ralf-Holger Voss
Hakim Echchannaoui
He Huang
Shao-An Xue

Frontiers in Immunology

doi 10.3389/fimmu.2023.1278677

1,915 views

Original Research

Published on 06 Sep 2023

Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy

in Cancer Immunity and Immunotherapy

Nisha Holay
Alexander Somma
Mark Duchow
Milad Soleimani
Anna Capasso
Srividya Kottapalli
Joshua Rios
Uma Giri
Jennifer Diamond
Anna Schreiber

Frontiers in Immunology

doi 10.3389/fimmu.2023.1260545

2,550 views
2 citations

Review

Published on 06 Sep 2023

The future of affordable cancer immunotherapy

in Cancer Immunity and Immunotherapy

Niels Schaft
Jan Dörrie
Gerold Schuler
Beatrice Schuler-Thurner
Husam Sallam
Shiri Klein
Galit Eisenberg
Shoshana Frankenburg
Michal Lotem
Areej Khatib

Frontiers in Immunology

doi 10.3389/fimmu.2023.1248867

19,207 views
42 citations

Review

Published on 06 Sep 2023

Molecular and immunological mechanisms of clonal evolution in multiple myeloma

in Cancer Immunity and Immunotherapy

Stefan Forster
Ramin Radpour
Adrian F. Ochsenbein

Frontiers in Immunology

doi 10.3389/fimmu.2023.1243997

7,388 views
17 citations

Correction

Published on 06 Sep 2023

Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma

in Cancer Immunity and Immunotherapy

Zhimin Zeng
Xiaoying Qian
Fanrong Liu
Yong Wang
Yong Yuan
Chen Fang
Xinwei Zhang
Shangkun Yuan
Renfang Chen
Biao Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1269596

1,906 views
1 citation

Original Research

Published on 06 Sep 2023

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer

in Cancer Immunity and Immunotherapy

Brandon Mistretta
Sakuni Rankothgedera
Micah Castillo
Mitchell Rao
Kimberly Holloway
Anjana Bhardwaj
Maha El Noafal
Constance Albarracin
Randa El-Zein
Hengameh Rezaei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188831

4,398 views
7 citations

Original Research

Published on 06 Sep 2023

TAGAP expression influences CD4+ T cell differentiation, immune infiltration, and cytotoxicity in LUAD through the STAT pathway: implications for immunotherapy

in Cancer Immunity and Immunotherapy

Zhanyu Xu
Tiaozhan Zheng
Zhiwen Zheng
Wei Jiang
Liuliu Huang
Kun Deng
Liqiang Yuan
Fanglu Qin
Yu Sun
Junqi Qin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1224340

6,461 views
2 citations

Review

Published on 06 Sep 2023

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

in Cancer Immunity and Immunotherapy

Bolin Wang
Jinli Pei
Shengnan Xu
Jie Liu
Jinming Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1246682

45,156 views
71 citations

Review

Published on 04 Sep 2023

The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma

in Cancer Immunity and Immunotherapy

Lingyun Zhang
Yu Jiang
Gao Zhang
Shiyou Wei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1238233

8,356 views
12 citations

Original Research

Published on 04 Sep 2023

Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling

in Cancer Immunity and Immunotherapy

Bui Que Tran Nguyen
Thi Phuong Diem Tran
Huu Thinh Nguyen
Thanh Nhan Nguyen
Thi Mong Quynh Pham
Hoang Thien Phuc Nguyen
Duc Huy Tran
Vy Nguyen
Thanh Sang Tran
Truong-Vinh Ngoc Pham

Frontiers in Immunology

doi 10.3389/fimmu.2023.1251603

6,563 views
7 citations